FOX 2′s Bonita Cornute Honored by the Empowerment Network

Posted on: 1:07 pm, December 19, 2012, by

IMG_0049

(KTVI) – Melve Shahid, founder of the Empowerment Network, presented FOX 2′s Bonita Cornute with an special thank you for her support of the organization. Cornute was the mistress of ceremonies at the organization’s annual Blue Tie Gala.

The Mission of “The Empowerment Network, Inc” is to heighten awareness, increase PSA testing and screening, provide information, resources, services, support, volunteerism and collaborative research that gives rise to filling the gaps in disparities that many uninsured and underinsured African American males, and their families, encounter when confronted with a prostate cancer diagnosis.
Company Overview
Objectives of The Empowerment Network Cancer Center are to efficiently and effectively reach populations of uninsured, underinsured, diagnosed and undiagnosed males (aged 35 years and over) and their families and to:

- Heighten awareness in terms of prostate and related cancers
- Increase PSA testing/screening
- Provide treatment referrals, education, resources and support
- Increase volunteerism
Description
The Empowerment Network, Inc (TEN) is a 501(c)(3) federally recognized nonprofit organization incorporated under Missouri State statutes. Over the past three years we have been very active in the struggle against Prostate Cancer across the Saint Louis Metropolitan area. While The Empowerment Network, Inc is relatively new as a group, our many years of service to academe and the community has pro…See More
General Information
The primary target populations of TEN are: African American males and their families, aged 35 and older, that have not been tested for cancer; and males and their families, aged 35 and older, that are survivors of prostate and related cancers. Research clearly indicates that the two populations mentioned here are most at-risk for prostate cancer. For example, African American males are 60% more likely than White males, similarly situated, to be diagnosed with prostate cancer, and more than two and a half times more likely to die from it.